Coexisting myasthenia gravis, myositis, and polyneuropathy induced by ipilimumab and nivolumab in a patient with non-small-cell lung cancer: A case report and literature review.

Abstract

RATIONALE Immune checkpoint inhibitors have led to the development of new approaches for cancer treatment with positive outcomes. However, checkpoint blockade is associated with a unique spectrum of immune-related adverse events (irAEs), which may cause irreversible neurological deficits and even death. PATIENT CONCERNS We presented a case of a 57-year… (More)
DOI: 10.1097/MD.0000000000009262

Cite this paper

@article{Chen2017CoexistingMG, title={Coexisting myasthenia gravis, myositis, and polyneuropathy induced by ipilimumab and nivolumab in a patient with non-small-cell lung cancer: A case report and literature review.}, author={Jia-Hung Chen and Kang-Yun Lee and Chaur-Jong Hu and Chen-Chih Chung}, journal={Medicine}, year={2017}, volume={96 50}, pages={e9262} }